Elagolix
Medication
>
Elagolix, sold under the brand name Orilissa, is a gonadotropin-releasing hormone antagonist medication which is used in the treatment of pain associated with endometriosis in women. It is also under development for the treatment of uterine... Wikipedia
AHFS/Drugs.com: Monograph
ATC code: H01CC03 (WHO)
Bioavailability: Low (5.8% in rats, 11% in monkeys; no human data)
Elimination half-life: Typical: 4–6 hours; Single dose: 2.4–6.3 hrs; Continuous: 2.2–10.8 hours
Metabolism: Liver (CYP3A)
Other names: NBI-56418, ABT-620
PDB ligand: F5O (PDBe, RCSB PDB)
Myfembree® (relugolix, estradiol, and norethindrone acetate) Safety & Prescribing Info. Find Patient Resources, Including Product Info...
An Rx For Moderate To Severe Pain Associated With Endometriosis In Premenopausal Women. Visit The HCP Website To Find Safety & Side Effects Information On An Rx Option.